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A B S T R A C T
Objective: Assess effect of diabetes self-management education and support methods, providers,
duration, and contact time on glycemic control in adults with type 2 diabetes.
Method: We searched MEDLINE, CINAHL, EMBASE, ERIC, and PsycINFO to December 2013 for
interventions which included elements to improve participants’ knowledge, skills, and ability to
perform self-management activities as well as informed decision-making around goal setting.
Results: This review included 118 unique interventions, with 61.9% reporting signiﬁcant changes in A1C.
Overall mean reduction in A1C was 0.74 and 0.17 for intervention and control groups; an average absolute
reduction in A1C of 0.57. A combination of group and individual engagement results in the largest
decreases in A1C (0.88). Contact hours 10 were associated with a greater proportion of interventions
with signiﬁcant reduction in A1C (70.3%). In patients with persistently elevated glycemic values (A1C > 9),
a greater proportion of studies reported statistically signiﬁcant reduction in A1C (83.9%).
Conclusions: This systematic review found robust data demonstrating that engagement in diabetes self-
management education results in a statistically signiﬁcant decrease in A1C levels.
Practice implications: The data suggest mode of delivery, hours of engagement, and baseline A1C can affect
the likelihood of achieving statistically signiﬁcant and clinically meaningful improvement in A1C.
ã 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Current estimates suggest that almost 50% of people with
diabetes do not achieve and sustain the recommended target of
<7.0% for glycated hemoglobin (A1C) [1] and only 14.3% are at
target goals for A1C, blood pressure, low-density lipoprotein
cholesterol, and nonsmoking [2]. The American Diabetes Associa-
tion 2015 Standards for Care as well as the American Association of
Clinical Endocrinologists recognize diabetes self-management
education (DSME) as an integral aspect of the care for people
with diabetes [1,3] in concert with pharmacotherapy that can
involve multiple medications and dosing algorithms [3]. Nonethe-
less, recent studies estimate that among those newly diagnosed
with diabetes, less than 7% of individuals with private insurance [1]
and less than 5% of those covered by Medicare [4] actually
participate in DSME. Thus, although the systematic review work by
Norris and colleagues [5,6] indicated that DSME resulted in clinical
improvement, it appears to be an underutilized element of
diabetes care. Notwithstanding the potential of tight glycemic
control to reduce complications [7], heightened awareness that
tighter glycemic control with antihyperglycemic medication can
be associated with increased risk of hyperglycemia [8] suggested
that a current review of the potential for clinical beneﬁt from DSME
which examined DSME characteristics of DSME interventions to
explore which, if any were associated with efﬁcacy, was warranted.
The National Standards for Diabetes Self-Management Educa-
tion and Support deﬁne diabetes self-management education as a
collaborative and ongoing process intended to facilitate the
development of knowledge, skills, and abilities that are required
for successful self-management of diabetes [9]. Alternatively
termed diabetes self-management training or DSMT, for clarity,
DSME will be the term used in this paper. Evidence from
randomized controlled trials and observational studies suggest
that DSME is cost-effective [10,11] and associated with favorable
changes in knowledge [12–16], clinical outcomes [13,14,16–18],
self-efﬁcacy and other psychosocial outcomes [16,19–21], screen-
ing for complications [15,22], risk factors for cardiovascular events
[22,23], and quality of life [22,24]. However, the association
between DSME and improvements in clinical endpoints and
patient-centered outcomes has not consistently been shown in
clinical trials or systemic reviews [5,6,17,25–29]. Differences in the
methods and providers of DSME [30], duration and intensity of
interventions, educational setting, demographic and clinical
characteristics of DSME recipients [30], and variations in the
quality of the research are proposed as factors that may contribute
to these inconsistent results [5,6,27,31,32]. While lending itself to
systematic review, this diversity of engagement is a hindrance to
meta-analysis.
This is a systematic review of published, randomized controlled
trials to evaluate the impact of DSME compared with usual care or
a minimal educational intervention on A1C levels in adults
diagnosed with T2DM. Because glycemic control has been shown
to strongly predict the microvascular and macrovascular compli-
cations of diabetes [7], we chose A1C as the clinical endpoint of this
study. We assessed changes in A1C levels that might be attributed
to the mode of delivery, provider type, duration, and baseline A1C.2. Methods
2.1. Data sources
Our research protocol was reviewed and approved by the
members of the 2013 Research Committee of the American
Association of Diabetes Educators (AADE). Preferred Reporting
Items for Systematic Reviews and Meta-Analysis (PRISMA) guide-
lines were followed [33] with the PICOS framing. Only studies
published in peer reviewed journals were included.
2.2. Search strategy
We searched MEDLINE accessed through PubMed, the Cumu-
lative Index to Nursing and Allied Health Literature, EMBASE,
Educational Resources Information Center, and PsycINFO. Our
search strategy used the National Library of Medicine Medical
subject headings including “type 2 diabetes,” “self-care education,”
“self-management,” and “behavior change.” We reviewed the titles
and abstracts (when available) of articles identiﬁed by the
systematic search as potentially relevant to evaluation of DSME.
All articles considered potentially relevant were retrieved and
reviewed for inclusion in this review.
Our search included English-language articles published from
January 1, 1997 through December 31, 2013. January 1, 1997 was
selected as the search initiation date because this was the year that
Congress authorized Medicare coverage of outpatient diabetes
self-management training in the Balanced Budget Act of 1997
which resulted in Medicare coverage for up to 10 hours of DSME in
the ﬁrst year of engagement. The systematic database searches
were supplemented with manual searches of citations from
relevant reviews, systematic reviews, and meta-analyses because
searches of online databases can be incomplete [34].
2.3. Study selection
This systematic review included was restricted to randomized
controlled trials (RCT), which are associated with optimal validity
and inference about causal relationships [35]. Our review was
limited to studies that included participants 18 years or older, with
any A1C level, all intervals of diabetes duration, and any comorbid
health conditions because it is not uncommon for people with
diabetes to be managing multiple conditions. In an effort for this to
be as comprehensive review as possible, trials enrolling
participants with type 1 and type 2 diabetes mellitus were
included if results were reported separately for participants with
T2DM or if the percentage of participants with type 1 diabetes was
less than 50% of the sample. DSME interventions provided in any
setting, by any method or provider, for any duration and contact
time were eligible for inclusion, though not every study reported
on each of these elements. However, because A1C was the clinical
endpoint of the review, to be eligible, studies were required to
report outcomes for A1C level.
Studies eligible for inclusion were also required to meet the
deﬁnition of DSME deﬁned by the National Standards for Diabetes
Self-Management Education and Support [9]. This deﬁnition is not
Table 1
Characteristics of eligible studies included in the systematic review.
Publication Baseline
age, mean
(Years)
Baseline A1c Change in A1c Intervention Control No.
randomly
assigned
No. at
ﬁnal FU
Final FU
(months)
Overall
retention
rate
Bias
rating
Unique
interv.
IG CG IG CG IG CG Mode Provider Duration
(months)
Est
contact
time
(hours)
IG CG IG CD
Agurs-
Collins
et al. [54]
62.4 61.0 11.0 10.0 1.1 1.5 C Team 6 27  One class on glycemic control
 2 mailings on nutrition
32 32 30 25 6 86.0 1 Y
Anderson
et al. [24]
55.5 55.7 7.7 7.5 I Team 24 NR  Metabolic assessments 156 154 122 126 24 80.0 3 Y
Battista et al.
[56]
60.0 59.0 7.9 7.7 0.6 0.3 I Single 24 4  Conventional care by endocrinologist 51 50 44 44 24 87.1 3 Y
Beverly et al.
[57]
59.9 58.4 8.5 8.3 0.5 0 G Team NR 4  Attention control of 2 two-hour classes on dyslipidemia
and hypertension
68 67 58 63 12 90.3 2 Y
Brown et al.
[18]
54.7 53.3 11.8 11.8 0.92 0.16 G Team 12 52  Wait-list control 126 126 117 112 12 90.9 2 Y
Carter et al.
[125]
52 49 9 8.8 2.18 0.9 R Single 9 NR  Standard of care 37 37 26 21 9 63.5 1 Y
Chen et al.
[58]
59.2 58.7 8.97 8.53 0.81 0.05 I Single <1 1  Invitation to attend outpatient, hospital-based education
in group and individual settings
125 125 104 111 3 86.0 2 Y
Choe et al.
[59]
52.2 51.0 10.1 10.2 2.1 0.9 I Single 12 NR  Usual medical care 41 39 36 29 24 81.3 2 Y
Clifford et al.
[61]
70.5 70.3 7.5 7.1 0.5 0 I Single 12 2.75  Usual care 99 99 92 88 12 91 2 Y
Cohen et al.
[62]
69.8 67.2 7.8 8.1 0.41 0.20 G Team 6 15.5  Standard of care at individual clinic visits about every
4 months
50 49 48 48 6 97.0 1 Y
Cooper et al.
[63]
59.0 59.0 8.4 7.9 0.1 1.0 G Single 2 16  Usual care for 6 months followed by educational
intervention
30 23 23 36 6 100 2 Y
Crasto et al.
[64]
62.6 60.3 7.9 8.0 0.8 0.2 C Team 18 6  Usual care by HCP according to local guidelines 94 95 89 89 18 94.2 2 N
Deakin et al.
[67]
61.3 61.8 7.7 7.7 0.6 0.1 G Single 1.5 12  Routine care plus diabetes education and review with RD
(30 min), RN (15 min), and GP (10 min)
157 157 150 141 14 92.7 2 Y
Farsaei et al.
[69]
53.4 52.9 9.3 8.9 1.8 0.10 I Single 3 NR  General education provided by nursing staff 87 87 87 87 3 100 2 Y
Gallegos
et al. [126]
52.0 49.5 10.36 9.44 2.32 0.33 C Single 12 39  Routine care consisting of monthly visit with physician 29 28 25 20 12 78.9 2 Y
Goudswaard
et al. [74]
62.6 58.7 8.2 8.8 1.0 0.4 I Single 6 2.5  Usual care by physician 25 29 24 26 18 92.6 2 Y
Huang et al.
[127]
56.6 56.9 8.0 8.4 0.7 0.2 C Single 12 4  Routine care 93 100 75 79 12 79.8 1 Y
Jacobs et al.
[128]
62.7 63.0 9.5 9.2 1.8 0.8 I Single 12 NR  Usual medical care 94 125 72 92 12 74.9 1 Y
Jarab et al.
[76]
63.4 65.3 8.5 8.4 0.8 0.1 I Single 2 >2.7  Usual medical services provided by clinic 85 86 77 79 6 91.2 2 Y
Johansen
et al. [77]
59.0 58.0 7.5 7.6 0.8 0.2 G Team 24 8.4  Standard care according to current ADA and national
guidelines
60 60 49 57 24 88.3 2 Y
Kim et al.
[79]
56.2 56.6 9.4 9.1 1.3 0.4 C Team 7.5 13.7  Delayed intervention 41 42 40 39 7.5 95.2 3 Y
Ko et al. [80] 53.3 54.1 9.4 9.2 1.5 0.5 C Team 15  Group education on diet, exercise, insulin, and moni-
toring with usual clinical care
219 218 160 148 48 70.5 1 Y
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Koev et al.
[146]
NR NR 9.1 8.7 0.48 0.17 G NR <1 7.5  No structured group education NR NR NR NR 6 NA 0 Y
Krass et al.
[81]
62.0 62.0 8.9 8.3 1 0.3 I Single 6 NR  2 visits with pharmacist at beginning and end of study 176 159 149 140 6 86.3 4 Y
Less et al.
[82]
56.6 58.6 7.95 8.03 0.63 0.59 C Single 6 NR  Usual care provided by health centers 159 159 158 135 6 92.1 3 Y
Lorig et al.
[83]
51.0 51.0 6.44 6.44 0.01 0.126 R Single 1.5 NR  Usual care 60 50 35 38 6 86.6 3 Y
Lorig et al.
[84]
52.9 52.8 7.44 7.38 0.41 0.05 C Single 1.5 15  Usual care 219 198 179 173 6 84.4 3 Y
Lujan et al.
[86]
58.0 58.0 8.21 7.71 0.46 0.3 G Single 6 16  Verbal information or 1–2 pamphlets on diabetes self-
management at routine clinic visits
75 74 71 70 6 94.6 2 Y
Maislos et al.
[132]
58.0 63.0 11.6 11.1 1.8 0.3 I Team 6 NR  Usual care 48 34 41 23 6 76.8 2 Y
McMurray
et al. [87]
63.0 60.9 6.9 6.9 0.6 0.3 I Team 12 NR  Standard diabetes care while at dialysis 49 42 45 38 12 91.2 3 Y
Mehuys et al.
[88]
63.0 62.3 7.7 7.3 0.6 0.1 I Single 6 NR  Usual pharmacist care 153 135 148 132 6 97.2 3 Y
Miller et al.
[89]
72.1 73.0 7.2 7.4 0.5 0 G Single 2.5 20  Wait-list control 45 47 45 47 2.5 100 3 Y
Mohamed
et al. [133]
52.0 55.0 8.67 8.61 0.8 0.19 G Single NR 16  Educational toolkit 215 215 109 181 12 67.4 1 Y
Mollaoglu
et al. [90]
53.2 51.8 9.5 9.7 2.0 0.1 C Single 2 1  Wait-list control 25 25 25 25 2 100 3 Y
Moriyama
et al. [91]
66.4 65.2 7.44 7.28 0.59 0.03 I Single 12 7  Educational textbook with usual care 50 25 42 23 12 86.7 2 Y
Munshi et al.
[92]
75.0 75.0 9.3 9.0 0.7 0.3 I Team 6 2.1  Attention control with 11 calls during ﬁrst 6 months with
no diabetes education, advice, or strategies discussed
70 30 67 26 12 93.0 2 Y
Oh et al.
[134]
59.2 62.0 8.8 8.3 1.1 0.7 R Single 3 7.2  Routine care 25 25 20 18 3 76.0 2 Y
Partapsingh
et al. [93]
NR NR 8.5 8.2 0.6 1.1 I Single 4 NR  Routine care 61 61 58 61 11 97.5 1 Y
Philis-
Tsimikas
et al. [136]
52.2 49.2 10.5 10.3 1.4 0.6 G Single 10 32  Usual medical care 104 103 55 71 10 60.9 1 Y
Piatt et al.
[94]
69.7 68.6 7.6 6.9 0.6 0.1 G Single 1.5 NR  Usual medical care 30 51 27 46 12 90.1 3 Y
Piatt et al.
[41]
69.0 66.3 7.4 7.1 0.3 0.5 G Single 1.5 NR  Usual medical care 30 51 15 24 36 48.1 2 N
Piette et al.
[95]
60.0 61.0 9.5 9.2 0.8 0 R Single 12 7.6  Usual care 146 146 132 140 12 93.2 2 Y
Pimazoni-
Netto et al.
[149]
54.5 58.4 10.29 10.01 2.26 1.29 I Team 3 10  FU visits at weeks 6 and 12 and 2 hours of education on
diabetes, nutrition, and exercise at baseline
32 31 32 29 3 NA 1 Y
Polonsky
et al. [137]
48.8 53.4 10.2 10.4 2.3 1.7 G Team <1 28  Usual diabetes care plus quarterlymailings for 12months 89 78 65 52 6 74.5 1 Y
Prezio et al.
[96]
47.9 45.7 8.9 8.7 1.6 0.9 I Single 12 7  Wait-list control 90 90 78 78 12 86.7 2 Y
Rachmani
et al. [97]
57.4 56.8 9.5 9.6 1.3 0.7 I Single NR 1.5  Standard consultation 71 70 65 64 48 91.5 2 Y
Rachmani
et al. [42]
NR NR 9.5 9.6 1.2 0.4 I Single NR 1.5  Standard consultation 71 70 56 54 96 78.0 1 N
Rosal et al.
[19]
62.7 62.4 7.7 9.3 0.85 0.12 C Team 2.5 31.5  Simple booklet about lifestyle factors in diabetes
management and recommendations for diet, physical
activity, and self-monitoring blood glucose
15 10 14 9 6 92.0 2 Y
Rosal et al.
[14]
NR NR 8.85 9.11 0.88 0.35 C Team 11 51  No intervention, usual care 124 128 NR NR 12 NA 1 Y
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Table 1 (Continued)
Publication Baseline
age, mean
(Years)
Baseline A1c Change in A1c Intervention Control No.
randomly
assigned
No. at
ﬁnal FU
Final FU
(months)
Overall
retention
rate
Bias
rating
Unique
interv.
IG CG IG CG IG CG Mode Provider Duration
(months)
Est
contact
time
(hours)
IG CG IG CD
Rothman
et al. [98]
54.0 57.0 11.0 11.0 2.5 1.6 C Single 12 7.7  1-h management session by pharmacist plus usual care 112 105 99 95 12 89.4 2 Y
Samuel-
Hodge
et al. [101]
57.0 61.3 7.8 7.8 0.5 0 C Team 12 25  2 educational pamphlets from ADA and 3 bimonthly
newsletters with general health information and study
updates by mail
117 84 101 69 12 84.6 3 Y
Sarkadi et al.
[102]
66.4 66.5 6.5 6.5 0.3 0.1 G Team 12 NR  Wait-list control 39 38 33 31 24 83.1 3 Y
Scain et al.
[150]
59.3 59.5 6.8 6.7 0.3 0.2 G Single 1 8  Usual care 52 52 NR NR 12 NA 1 Y
Skelly et al.
[106]
60.5 63.7 9.2 9 1.27 0.54 I Single NR 6  Phone call at midpoint between baseline and ﬁnal
evaluation and a copy of Taking Charge of Your Diabetes
23 18 22 17 2 95.1 2 Y
Sone et al.
[107]
59.4 59.4 7.68 7.8 0.15 0.1 I Team 36 19.5  Conventional care 1105 1100 990 983 36 89.5 3 Y
Song et al.
[139]
51.0 49.5 9.4 9.0 2.3 0.4 C Team 3 14.5  1-hour of diabetes education, medical nutrition therapy,
recommendation for physical activity provided by
diabetic education nurse and usual medical care
25 24 20 19 3 79.6 1 Y
Spencer et al.
[108]
50.0 55.0 8.6 8.5 0.8 0 C Single 6 24  Wait-list control
 Contact by phone once per month to update contact
information
72 92 59 77 6 82.9 2 Y
Sperl-Hillen
et al. [50]
61.6 63.3 8.14 8.0 0.51 0.24 I Team 3 3  Usual care 246 134 209 108 6.8 81.3 2 Y
Sperl-Hillen
et al. [50]
61.2 63.3 8.07 8.0 0.27 -0.24 G Team 1 8  Usual care 243 134 195 108 6.8 80.4 2 Y
Sun et al.
[110]
51.0 51.0 7.1 7.0 0.85 0 I Team 6 12  All study participants were provided diabetes education
materials used in lectures given by nutritionists including
information on diabetes management, behavior and
lifestyle changes, physical activity, healthy eating, and
low-glycemic foods
100 50 97 49 6 97.3 2 Y
Tan et al.
[111]
54.0 54.0 9.9 9.6 1.15 0.07 C Single 3 1.5  Usual care 82 82 78 73 3 92.1 2 Y
Tang et al.
[22]
54.0 53.5 9.24 9.28 1.14 0.95 C Team NR 2.5  Usual care 202 213 186 193 12 91.3 2 Y
Taveira et al.
[113]
62.2 66.8 8.1 7.9 0.9 0 G Team 1 8  Standard of care 64 54 58 51 4 92.4 2 N
Taveira et al.
[112]
60.2 61.4 8.3 8.5 0.9 0.1 G Team 6 18  Standard of care 44 44 44 41 6 96.6 1 Y
Taylor et al.
[141]
55.5 54.8 9.5 9.5 1.14 0.35 C Single 12 11.75  Usual care plus diabetes pamphlets and Medic Alert
pamphlet
84 85 61 66 12 75.1 1 Y
Thom et al.
[142]
56.3 54.1 10.05 9.55 1.07 0.3 I Single 6 NR  Usual care including access to nutritionist and diabetes
educator through referral
148 151 122 114 6 78.9 1 Y
Toobert et al.
[153]
NR NR 7.43 7.4 0.36 0.02 G Team 6 111  Usual medical care 163 116 137 108 6 87.8 2 Y
Toobert et al.
[143]
55.6 58.7 8.4 8.2 0.5 0.1 G Team 12 159  Usual medical care 142 138 109 108 12 77.5 1 Y
930
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Trento et al.
[154]
62.0 61.0 7.4 7.4 0.1 0.9 G Team 24 6.7  Usual medical care every 3 months 56 56 43 47 24 80.4 2 Y
Trento et al.
[45]
62.0 61.0 7.4 7.4 0.4 1.2 G Team 48 12.5  Usual medical care every 3 months 56 56 45 45 48 80.4 2 N
Trento et al.
[46]
62.0 61.0 7.4 7.4 0.1 1.6 G Team 60 15.8  Usual medical care every 3 months 56 56 42 42 60 75.0 1 N
Walker et al.
[114]
55.7 55.4 8.6 8.7 0.23 0.13 R Single 12 1.9  Active control including print materials on self-man-
agement by mail
262 264 228 216 12 84.4 2 Y
Wattana
et al. [115]
58.4 55.1 8.08 8.09 0.68 0.07 C Single NR 9.5  Wait-list control 79 78 75 72 6 93.6 2 Y
Weinger
et al. [51]
51.8 54.7 9.12 9.09 0.82 0.42 G Single 1.5 10  Attention control using didactic curriculum and same
length of time and amount of contact with HCPs and
homework
74 75 66 70 12 91.3 2 Y
Weinger
et al. [51]
56.2 54.7 8.9 9.09 0.37 0.42 G Single 6 4.5  Attention control using didactic curriculum and same
length of time and amount of contact with HCPs and
homework
73 75 66 70 12 91.9 2 Y
Welch et al.
[116]
54.4 57.5 9.0 8.5 1.6 0.6 I Team 12 7  Attention control consisting of seven 1-h visits over
12 months to review diabetes education booklets with
clinic staff
25 21 21 18 12 84.8 2 Y
White et al.
[117]
53.0 58.0 10.5 10.1 2.1 1.2 I Team NR 460  One-time disease management session with pharmacist
and usual medical care
112 105 NR NR 12 88.9 2 Y
Williams
et al. [119]
58.4 56.4 8.7 8.9 0.8 0.2 R Team 6 5.5  Quarterly newsletter with general health information
and usual medical care
57 60 48 55 6 85.8 3 Y
Young et al.
[121]
67.0 67.0 7.9 8.0 ? ? R Team 12 NR  Conventional treatment 394 197 332 176 12 85.6 2 Y
Baseline
Age, Mean
(Years)
Baseline
A1c
Change in A1c Intervention Control No.
Randomly
Assigned
No. at
Final FU
Final FU
(Months)
Overall
Retention
Rate
Bias
Rating
Unique
Interv.
IG CG IG CG IG CG Method Provider Duration
(Months)
Est
Contact
Time
(Hours)
IG CG IG CG
Adolfsson et al.
[53]
62.4 63.7 7.4 7.1 0.1 0.3 G Single 7 12.5  Routine care 50 51 42 46 12 87.1 3 Y
Agema et al. [122] 55.6 61.7 7.7 8.4 0.06 0.66 I Single NR NR  Routine clinical care 30 30 18 14 2.4 53.3 2 Y
Anderson et al.
[55]
61.0 61.0 8.74 8.41 0.3 0.28 G Team 1.5 12  Wait-list control 125 114 117 108 1.5 94.1 1 Y
Anderson et al.
[123]
NR NR 7.6 8.4 0.06 0.66 R Single 12 NR  Usual primary care 146 149 94 117 12 71.5 0 Y
Anderson-Loftin
et al. [124]
58.9 55.7 7.5 8.3 0.5 0.3 C Team 6 10  Referral to local 8-h traditional diabetes class and
phone fu at 3 months by RA to maintain contact
49 48 38 27 6 67.0 1 Y
Cade et al. [38] 65.4 66.2 7.3 7.5 0.3 0.1 G Single 1.75 14  Standard care consisting of a single 15–30min
appointment with RD
162 155 86 108 12 61.2 1 N
Christian et al.
[60]
53.0 53.4 8.08 8.29 0.14 0.46 I Single 9 NR  Health education materials plus usual care 155 155 141 132 12 88.1 2 Y
Crowley et al. [65] 56.0 57.0 8.0 8.0 0.2 0.1 R Single 12 2.8  Usual medical care plus written educational
materials at baseline
182 177 180 172 12 98.1 2 Y
Davies et al. [66] 59.0 60.0 8.3 7.9 0.15 0.12 G Single <1 6  Enhanced standard care 437 387 404 345 12 90.9 3 Y
Khunti et al. [40] 59.4 61.0 8.3 7.7 1.32 0.81 G Single <1 6  Enhanced standard care 437 387 332 272 36 73.3 2 N
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Table 1 (Continued)
Baseline
Age, Mean
(Years)
Baseline
A1c
Change in A1c Intervention Control No.
Randomly
Assigned
No. at
Final FU
Final FU
(Months)
Overall
Retention
Rate
Bias
Rating
Unique
Interv.
IG CG IG CG IG CG Method Provider Duration
(Months)
Est
Contact
Time
(Hours)
IG CG IG CG
Edelman et al.
[68]
63.0 60.8 9.2 9.2 0.9 0.6 G Team 12 14  Usual medical care 133 106 122 89 12.8 88.3 2 Y
Frosch et al. [70] 56.7 54.3 9.4 9.8 0.5 0.6 R Single NR 2.5  Brochure on diabetes self-care 100 101 83 87 6 84.6 2 Y
Gabbay et al.
[144]
65.0 64.0 7.46 7.36 0.01 0.04 I Single 12 NR  Usual care 150 182 NR NR 12 NA 1 Y
Gary et al. [71] 59.0 56.0 7.7 8.0 0.2 0.8 I Team 24 NR  Mail and phone FU by NHCP every 6 months with
reminders about preventive screening and infor-
mational mailings every 3–4 months
269 273 235 253 24 90.0 2 Y
Gary et al. [52] 59.0 57.0 8.8 8.5 0.3 NR I Single 24 4.5  Usual medical care plus quarterly diabetes
newsletter
NR NR 38 34 24 NA 1 Y
Gary et al. [52] 59.0 57.0 8.4 8.5 0.25 NR I Single 24 6  Usual medical care plus quarterly diabetes
newsletter
NR NR 41 34 24 NA 1 Y
Gary et al. [52] 60.0 57.0 8.6 8.5 0.8 NR I Team 24 10.5  Usual medical care plus quarterly diabetes
newsletter
NR NR 36 34 24 NA 1 Y
Glasgow et al.
[73]
62.0 61.0 7.4 7.5 0.1 0 R Single 2 1  Health risk appraisal, feedback, and brief, generic
health habit change counseling
174 161 153 148 2 89.9 4 Y
Glasgow et al.
[72]
58.2 58.7 8.13 8.06 0.18 0.06 R Single 2 NR  Enhanced usual care 331 132 260 115 4 81.0 4 Y
Glasgow et al.
[39]
58.2 58.7 8.14 8.16 0.02 0.12 C Team 12 6  Enhanced usual care 331 132 244 114 12 77.3 3 N
Hawthorne et al.
[75]
52.0 54.0 8.4 8.6 0.1 0.04 I Single NR NR  Usual medical care 112 89 106 86 6 95.5 2 Y
Keeratiyutawong
et al. [78]
NR NR 8.9 7.9 0.73 0.21 G Single <1 10  Written diabetes materials at baseline and
5 videos about diabetes care at clinic visits
45 45 40 41 6 90.0 2 Y
Keyserling et al.
[47]
58.5 59.2 10.7 11.3 0.1 0.6 C Team 12 6.6  Educational pamphlet mailings 67 67 54 57 12 82.8 2 Y
Keyserling et al.
[47]
59.8 59.2 11.0 11.3 0.1 0.6 I Single 6 3.3  Educational pamphlet mailings 66 67 59 57 12 84.2 2 Y
Kim et al. [129] 56.6 54.7 7.4 7.41 0.33 0.17 I Single 4 10.8  Booklet with basic educational advice on usual
care for diabetes
27 27 21 22 4 79.6 1 Y
Ko et al. [130] 55.0 56.0 8.6 8.4 0.5 0.2 I Single 12 2.5  Usual medical care 90 90 90 88 12 98.9 2 Y
Krier et al. [131] 54.2 56.2 9.6 10.0 0.4 0.9 I Single 9 0.75  Physician FU every 3 months 21 18 14 9 9 59.0 1 Y
Lorig et al. [85] 67.7 65.4 6.74 6.7 -0.11 -0.17 G Single 1.5 15  Usual care 186 159 161 133 6 85.2 3 Y
Mayer-Davis et al.
[48]
58.9 62.4 9.7 9.6 0.84 1.12 C Single 12 4  Usual care delivered by study nutritionist on diet
and physical activity
NR NR 47 56 12 NA 1 Y
Mayer-Davis et al.
[48]
59.7 62.4 10.2 9.6 1.56 1.12 I Single 12 26  Usual care delivered by study nutritionist on diet
and physical activity
NR NR 49 56 12 NA 1 Y
Osborn et al.
[135]
56.9 58.4 7.76 7.45 0.48 0.27 G Team <1 1.5  Usual care including medical treatment, physician
monitoring, and optional support group w group-
based didactic diabetes education
59 59 48 43 3 77.1 1 Y
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Rosenbek Minet
et al. [20]
57.1 55.8 7.02 7.03 0.14 0.26 I Team 12 3.75  Usual care following 4-day educational course also
provided to IG
173 176 145 153 24 85.4 2 Y
Ruggiero et al.
[99]
NR NR 8.9 8.5 0.59 0.24 I Single 6 2  Treatment as usual plus basic diabetes education
handbook
25 25 24 18 6 84.0 2 Y
Rygg et al. [100] 66.0 66.0 7.1 6.9 0.1 0.2 G Team 2.25 15  Wait-list control 73 73 64 69 12 91.1 3 Y
Sacco et al. [138] 52 52 8.4 8.5 1.0 0.7 R Single 6 4.7  Treatment as usual from board-certiﬁed endo-
crinologist
31 31 21 27 6 77.4 1 Y
Sevick et al. [103] NR NR 7.7 7.5 0.6 0.2 G Team 6 NR  Attention control including group seminars on
general diabetes education and stress manage-
ment and receipt of lay diabetes magazine
147 149 120 126 6 93.5 3 Y
Shibayama et al.
[104]
61.0 62.0 7.3 7.4 0.1 0 I Single 12 5  Usual care 67 67 61 59 12 89.6 2 Y
Sixta et al. [105] 54.5 52.8 7.32 7.65 G Single 2.5 15  Wait-list, usual care 63 68 NR NR 6 80 2 Y
Skelly et al. [49] 68.5 68.0 8.44 8.11 0.44 0.56 I Single 6 4  Attention control based onweight and diet control
program with 4 modules delivered in 60-minute
sessions
60 60 54 55 9 90.1 3 Y
Skelly et al. [49] 65.0 68.0 8.33 8.11 0.75 0.56 I Single 6 5  Attention control based onweight and diet control
program with 4 modules delivered in 60-minute
sessions
60 60 54 55 9 90.1 3 Y
Sperl-Hillen et al.
[43]
62.0 62.0 8.11 8.09 0.35 0.42 I Team 3 3  Usual care 246 134 232 124 12.8 93.7 2 N
Sperl-Hillen et al.
[43]
62.0 62.0 8.07 8.09 0.31 0.42 G Team 1 8  Usual care 243 134 227 124 12.8 93.1 2 N
Steed et al. [140] 59.2 60.3 8.39 8.65 0.26 0.15 G Team 4.25 15  Wait-list control 65 59 53 53 3 73.4 1 Y
Sturt et al. [109] 62.0 62.0 8.9 8.8 0.5 0.4 I Single 3 12.25  Delayed intervention 114 131 88 114 6.5 82.4 3 Y
Taylor et al. [151] 58 67 7.69 7.69 0.29 0.72 I Team 3 4.5  Standard medical care 20 19 NR NR 4 NA 1 Y
Thomas et al.
[152]
51.4 52.2 8.9 9.0 0.7 0.5 G Single NR 3  Usual care 54 61 NR NR 6 NA 1 Y
Toobert et al. [44] 55.6 58.7 8.4 8.4 0 0.6 G Team 24 171  Usual medical care 142 138 97 93 24 58.9 1 N
Whittemore et al.
[118]
57.6 57.6 7.7 7.6 0.2 0.1 I Single 6 NR  Standard diabetes care every 3–4 months with
HCP
29 24 26 23 6 92.5 2 Y
Wolever et al.
[120]
53.1 52.8 7.9 8.1 0.4 0.1 I Single 6 7  No intervention 30 26 27 22 6 87.5 3 Y
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934 C.A. Chrvala et al. / Patient Education and Counseling 99 (2016) 926–943prescriptive but rather is process oriented; DSME interventions
had to include elements and activities intended to improve
participants’ knowledge, skills, and ability to perform self-
management activities that had the potential to improve glycemic
control. The DSME intervention was also required to adhere to a
process of informed decision-making that included goal setting in
1 or more areas of self-management, with goals tailored to
individual participants and collaboratively established between
the provider(s) of DSME and the person with diabetes. Inter-
ventions that provided only medical nutrition therapy or medica-
tion management were excluded.
2.4. Data extraction
Data for all eligible publications were abstracted by the ﬁrst
author and conﬁrmed by a second reviewer using a standardized,
structured evidence table. Any discrepancies in the evidence
summary were resolved by consensus among the 3 authors. Data
abstraction was not blinded to author, institution, year of
publication, or journal. We included only data reported in each
publication, although we contacted authors to clarify information
about the educational method, duration of the intervention,
estimated contact hours, and reductions in A1C for 17 publications.
We used data (mean, standard deviation, and sample size)
reported in 19 publications to calculate the statistical signiﬁcance
of changes in A1C from baseline to follow-up [36]. Even within the
context of randomized clinical trials, DSME was found to be a
heterogeneous intervention and so we used the information
provided by the authors to parse the studies by mode of delivery,
provider type, duration, and baseline A1C in an effort to
understand the contribution of these factors on the impact of
DSME on glycemic control. Examination of these DSME character-
istics was undertaken to determine whether any was associated
with efﬁcacy of the intervention.
Information recorded about each study included a description
of the intervention and comparison group(s), clinical and
demographic characteristics of participants, and characteristics
of the DSME intervention. Mode of delivery and DSME provider
type, estimated maximum contact hours for DSME, follow-up
interval and frequency, statistical methods, clinical outcomes, and
study limitations noted in the publication were recorded.
2.5. Mode of delivery
Modes of DSME delivery were classiﬁed into 1 of 4 categories:
(1) individual education, (2) group education, (3) a combination of
individual and group education, and (4) DSME primarily delivered
by remote methods, with subject contact conducted online or by
telephone.
2.6. Provider type
DSME was provided by a diverse group of healthcare
professions including physicians, nonphysician healthcare pro-
fessionals (e.g., credentialed diabetes educator, dietitian, exercise
physiologist, registered nurse, pharmacist, physical therapist,
occupational therapist, psychologist, or a social worker) as well
as non-healthcare professional (NHCP) such as community health
workers and health navigators. However, for purposes of this
systematic review, DSME was categorized as being delivered by a
solo (S) or a team (T) provider (i.e., two or more individuals were
involved with provision of DSME to the study participants).2.7. Duration of DSME
Efﬁciency of care is of economic concern with respect to
diabetes and other conditions the maximum contact time per
subject during the DSME intervention was determined for all
studies reporting this information. Because current Medicare
policy in the US caps reimbursement for DSME at 10 hours in the
ﬁrst year of DSME engagement and 2 hours per year thereafter, we
examined the efﬁcacy of DSME in studies in which the engaged
participants in programs of DSME involving < or = 10 hours
compared with those studies involving >10 hours of DSME. Table 1
lists duration of DSME intervention as well as length of follow-up.
Final A1C measure was taken at ﬁnal follow-up which in many
cases was after DSME intervention.
2.8. Baseline A1C
Another parameter that varied widely among the RCT reviewed
was the participant characteristic of baseline A1C and therefore the
impact of this variable was examined in the context of this
systematic review. Outcomes for both the proportion of studies
with statistically signiﬁcant differences as well as the average
improvement in A1C observed was evaluated in terms of quartile of
baseline A1C.
2.9. Assessment of study quality and validity
The evaluation of study quality was modelled after earlier
systematic reviews [5,6] and determined by information reported
in each publication. Internal validity was evaluated for selection,
performance, attrition, and detection bias as deﬁned by the
Cochrane Collaboration Criteria [37]. These included appropriate-
ness of the statistical methodology employed as well as the
number of subjects enrolled and randomized to the intervention
group (IG) and control group (CG) at baseline and follow-up.
Studies were assigned a score ranging from 0 to 4, with a score of
4 indicating that the study met the criteria for each of the
4 potential sources of bias and a score of 0 indicating that none of
the criteria were met.
Studies were evaluated for the presence of statistically
signiﬁcant differences between the IG and CG at baseline as a
measure of selection bias. If signiﬁcant baseline differences were
reported, the statistical analysis was reviewed to determine if
measures had been taken to adjust for potential confounders. Most
studies reported their methods of randomization. However,
selection bias was a concern for studies that enrolled participants
selected from an accessible population who volunteered to
participate in the study or were convenience samples. We also
examined studies for performance bias to determine the risk of
possible contamination between the IG and CG and identiﬁcation
of treatment differences between the IG and CG other than the
DSME intervention.
Whenever possible, we recorded retention rates reported in the
publication or calculated these rates based on data reported in the
article as a measure of attrition bias. Retention was considered as a
possible source of bias for studies with retention rates <80%, while
retention rates 80% were considered acceptable to reduce the risk
of attrition bias, which is consistent with the Cochrane Collabora-
tion Criteria [37].
We evaluated each publication for detection bias attributable to
systematic differences in outcomes between the IG and CG that
might be due to lack of blinding of participants, investigators,
intervention providers, and study personnel who performed the
outcome assessment and statistical analysis. We also considered
the use of indirect measures of A1C (e.g., self-report) as an
additional source of detection bias.
C.A. Chrvala et al. / Patient Education and Counseling 99 (2016) 926–943 9352.10. Categorization of interventions
The majority of eligible publications reported the effect of a
single, discrete DSME intervention on a deﬁned population with
1 follow-up assessments of A1C at varying time intervals
3 months or greater. Each of these was considered a unique
intervention. Outcomes from some studies were reported in
multiple publications with the ﬁrst publication describing the
DSME intervention, study population, and initial follow-up results
for A1C. Subsequent publications reported A1C results for longer
follow-up intervals for the same participants and DSME interven-
tion. The initial publication was classiﬁed as a unique intervention
while the additional follow-up data on A1C reported in subsequent
publications were not. They were included in our assessment of
changes in A1C attributable to the unique DSME intervention
described in the initial publication. Finally, several studies
compared 2 or 3 methods of DSME to the control condition within
a single publication. Each intervention arm of the publication was
counted as a unique intervention delivered to different groups of
participants. This categorization plan allowed us to evaluate the
effects of DSME at the level of unique intervention.
2.11. Evaluation of changes in A1C
The studies expressed changes in A1C between the IG and CG in
various ways, including absolute A1C at baseline compared withFig. 1. Summary of evidence identiﬁcatioA1C levels at each follow-up assessment, absolute or relative
change from baseline, and/or percent of participants who met
glycemic targets at each follow-up compared with baseline. For the
purpose of this review, we evaluated changes in A1C by 2 methods.
First, we calculated the percentage of unique interventions that
reported a signiﬁcant difference in A1C between the IG and the CG
at 1 or more follow-up assessments, with interventions that did
not achieve a signiﬁcant difference between the IG and CG at any
follow-up assessment categorized as not signiﬁcant. Second, we
examined the changes in A1C between the IG and CG for all unique
interventions and calculated the absolute difference in A1C
between IG and CG for a given category of intervention or patient
population. We examined variations in the percentage of statisti-
cally signiﬁcant and not signiﬁcant interventions and degree of
change in A1C for all unique interventions and unique inter-
ventions associated with a signiﬁcant decrease in A1C by method
of DSME, DSME provider, duration of DSME, and maximum contact
time associated with the delivery of DSME. Differences in A1C
utilizes the term ‘change’ rather than ‘reduction’ to simplify
capture all outcomes including those from studies in which there
was an observed increase in A1C in the CG.
3. Results
Our study selection process yielded a total of 3095 non-
duplicated publications, with 2821 excluded and full-text reviewn and selection for study inclusion.
936 C.A. Chrvala et al. / Patient Education and Counseling 99 (2016) 926–943completed for 274 articles. In addition to excluding publications
that were not primary clinical trials (Other Reasons), the most
common reasons for exclusion from this review were failure of the
intervention to meet established criteria for DSME or omission of
A1C as a study endpoint (Fig. 1). We identiﬁed 118 unique DSME
interventions published in 120 articles that met our inclusion
criteria. Nine publications reported additional follow-up results for
a unique intervention delivered to the same population [38–46].
These publications were counted as non-unique interventions.
Six publications compared 2 methods of DSME to control
[43,47–51] and 1 trial compared 3 methods of DSME [52] to the
control group(s). Each IG arm in these 7 publications was counted
as a unique intervention.
A total of 11,854 and 11,093 participants were enrolled in an IG
and CG, respectively, with a mean age of 58.5 years (standard
deviation [SD], 5.21; range, 47.9–75.0) for the IG and 58.7 (SD, 5.35;
range, 45.7–75) for the CG. The median age at baseline was 58.5
years for both IG and CG participants and the median baseline A1C
was 8.4 for both the IG and CG, with a mean of 8.55 (SD, 1.11; range,
6.4–11.8) for IG and 8.48 (SD, 1.08; range, 6.4–11.8) for CG
participants.
Retention rates were 80% for 71.2% of the interventions
[18–20,22,24,47,49–51,53–121], <80% for 18.6% [122–143], and
insufﬁcient data were available to determine retention rates for
12 interventions (10.2%) [7,14,48,52,144–152]. Higher subject
retention rates were associated with interventions that reported
a signiﬁcant change in A1C following DSME at 94.5% compared
with 80.0% for those that were not associated with a signiﬁcant
change in A1C.
Follow-up A1C results of greater than 3 months duration were
reported for 11,584 IG participants and 10,466CG participants. A
total of 73 (61.9%) unique interventions demonstrated signiﬁcant
differences between the IG and CG [14,18,19,22,24,50,51,54,
56–59,61–64,67,69,74,76,77,79,81,82,84–98,101,102,106,108,110–
114,117,119,125–128,130,132–134,136,137,139,141–143,146,149,
150,153,154] compared with 45 (38.1%) interventions that
resulted in no signiﬁcant differences (Table 1) [20,47–49,51–
53,55,60,65,66,68,70–73,75,78,80,83,99,100,103–105,109,118,120–
124,129,131,135,138,140,144,151,152].
3.1. Characteristics of interventions
Because of intervention heterogeneity, it was not appropriate to
conduct a meta-analysis. Interventions differed with respect to a
number of factors with potential to impact outcomes such as
clinical and demographic characteristics of participants; mode of85.71
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Fig. 2. Mode oDSME delivery, DSME provider, estimated maximum duration
and maximum contact hours; frequency and duration of follow-up
assessments; and quality (Table 1). Individual DSME was delivered
in 49 (41.5%) of the studies [20,24,47–51,56,58–61,69,71,74–
76,80,81,87,88,91–93,96,97,99,104,106,107,109,110,116–118,120,
122,128,129,131,132,142,144,149,151], with 35 (29.7%) administer-
ing the intervention in a group setting [18,50,51,53,55,57,62–
64,66–68,77,78,83,86,89,94,100,102,103,105,112,113,133,135–137,
140,143,146,150,152–154], 21(17.8%) providing DSME as a combi-
nation of individual and group education [14,19,22,47,
48,54,79,82,85,90,98,101,108,111,115,124,126,127,130,139,141], and
10.2% engaging people primarily through remote education
[65,70,72,73,84,114,119,121,123,125,134,138]. One study did not
report the mode of DSME delivery [95]. Single DSME providers
were used in 71 (60.2%) of interventions [48,49,54,56,58–61,63,65–
67,69,70,72–76,78,80,81,83–86,88–91,93–99,104–106,108,109,
111,114,115,118–123,125–129,131,133–136,138,141,142,144,150,152]
and 46 (39.0%) studies [14,18–20,22,24,47,50–55,57,62,
64,68,71,77,79,87,92,100–103,107,110,112,113,116,117,124,130,132,
137,140,143,149,151,153,154] provided team-based DSME. One
study did not report the provider of DSME. [146] Median DSME
duration was 6 months (mean, 8.14; SD, 6.75; range, 1–36). Eleven
interventions [22,57,70,75,97,106,115,117,122,133,152] did not re-
port or provide sufﬁcient information to determine DSME
duration. Mean DSME contact time was 18.26 (SD, 51.10; range,
0.75–460) hours in 92 interventions [14,18–20,22,47–58,61–
68,70,73,76–80,83,85,86,89–92,96–101,104–117,119,120,124,
126,127,129–131,133–141,143,146,149–154], while 26 (22.0%) inter-
ventions [24,59,60,69,71,72,75,81,82,84,87,88,93–95,102,103,
118,121,123,125,128,132,142,144] did not report or provide ade-
quate information to calculate mean DSME contact time.
3.2. Percentage of interventions with signiﬁcant changes in A1C
Eighty-six percent of interventions based on combination
DSME achieved signiﬁcant improvements in A1C [14,19,22,
54,79,82,85,90,98,101,108,111,115,126,127,130,139,141], which was
higher than group, individual, or remote modes of DSME delivery
(Fig. 2). Examination of changes in A1C associated with DSME
provider revealed that 69.6% of team interventions
[14,18,19,22,24,50,51,54,57,62,64,77,79,87,92,101,102,107,110,112,1-
13,116,117,130,132,137,139,143,149,153,154] were associated with
signiﬁcant changes in glycemic control compared with 56.3% of
DSME interventions conducted by a solo provider (Fig. 3)
[56,58,59,61,63,67,69,74,76,81,82,84–86,88–91,93–98,106,108,111,
114,115,119,125–128,133,134,136,141,142,150]. While the41.67
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Fig. 3. DSME provider.
C.A. Chrvala et al. / Patient Education and Counseling 99 (2016) 926–943 937proportion of interventions reporting statistically signiﬁcant
differences between IG and CG was greater for those interventions
provided by a team versus a solo provider, Pearson’s chi-square
analysis did not ﬁnd these proportions to be signiﬁcantly different
(p = 0.08). In addition the mean change in A1C of 0.74 was the
same regardless of whether the provider was a single individual or
a team.
In order to examine the effect of baseline A1C on response to
DSME, we calculated quartiles for baseline A1C with the ﬁrst
quartile consisting of participants with A1C <7.7%, the second
quartile ranging from 7.7% to 8.3%, the third quartile ranging from
>8.3% to 9%, and A1C >9% comprising the top quartile. A greater
percentage of studies that enrolled participants with higher
baseline A1C levels reported signiﬁcant changes in A1C following
exposure to DSME (Fig. 4) [18,22,51,54,59,69,79,90,92,95,97,98,
106,111,117,126,128,130,132,136,137,139,141,142,146,149].
We also evaluated the effect of intervention duration on
changes in A1C by calculating quartiles for length of DSME delivery
duration. The 4 quartiles for DSME delivery duration were 2.5
months, >2.5 to <6 months, >6 to <12 months, and >12 months. Six
(60%) of interventions in the top quartile for DSME duration
achieved a signiﬁcant improvement in A1C [24,56,64,77,107,154]
compared with 17 (65.4%) interventions provided for durations of
2.5 or fewer months (Fig. 5) [19,50,51,58,63,67,76,84,85,89,90,
94,113,130,137,146,150]. DSME contact time >10 hours was
associated with signiﬁcant improvements in A1C in 86 (70.27%)
interventions [14,18,19,54,62,63,67,79,85,86,89,101,107,108,
110,112,117,126,130,133,136,137,139,141,143,153] compared with53
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Fig. 4. Basel31 (56.4%) interventions with DSME contact times 10 hours
[22,50,51,57–59,61,64,74,77,90–92,96–98,106,111,113–116,119,127,
128,134,146,149, 150,154] (Fig. 6). Pearson chi-square analysis
found the ratio of signiﬁcant to non-signiﬁcant change in A1C to be
signiﬁcantly greater for those interventions engaging participants
in DSME for more than 10 hours as compared to those engaging
participants in DSME for 10 hours or less (p = 0.04).
3.3. Overall changes in A1C
The overall mean reduction in A1C for all participants
randomized to DSME was 0.74 (SD, 0.63) with a range of 0.6 to
2.50 and a median of 0.60 versus a mean decrease of 0.17 (SD,
0.50), range 1.5 to 1.7, and median of 0.12 for all CG participants
(Table 2). Combination DSME was associated with the greatest
change in A1C compared with group, individual, and remote
interventions. There were no differences in the mean change in
A1C between single or team DSME providers while DSME hours
that exceeded 10 were associated with a slightly higher overall
mean reduction in A1C (Table 2). Additional details about the
median and range for overall changes between the IG and CG
associated with DSME method, provider, and contact hours are
summarized in Table 2.
3.4. Signiﬁcant reductions in A1C
As an approach to examining the real potential for DSME to
affect glycemic control, when we limited our assessment to83.9
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938 C.A. Chrvala et al. / Patient Education and Counseling 99 (2016) 926–943interventions associated with a statistically signiﬁcant decrease in
A1C at 1 or more follow-up assessments, the overall mean A1C
reduction for participants exposed to DSME was 0.80 compared
with 0.21 for all CG participants (Table 2). Our examination of
changes in A1C by method of DSME limited to studies that reported
a signiﬁcant decrease in A1C revealed the largest mean reduction
for combination DSME at 1.22 compared with a mean reduction of
0.14 for participants randomized to a CG, followed by individual
interventions that resulted in a mean reduction of 1.14 for IG
participants versus 0.37 in the CG. The smallest reduction in A1C
levels was evident for group DSME (Table 2).
There were only nominal differences between DSME delivered
by a single provider compared with a team for interventions
demonstrating signiﬁcant decreases in A1C between the IG and the
CG (Table 2). The improvement in glycemic control for DSME
interventions resulting in signiﬁcant decreases in A1C was slightly
higher for interventions that offered 10 contact hours with a
mean decrease of 1.01 for participants exposed to more than
10 hours of DSME and 0.96 for participants who received 10
hours of DSME (Table 2).
Examination of the range of A1C reductions for the 69 studies
that reported signiﬁcant decreases revealed reductions that
exceeded 2% in the IG regardless of DSME method, provider, and
contact hours. In comparison, A1C levels for participants
randomized to a CG in these 69 studies ranged from a maximum
of 1.7 for group, team, and contact hours >10 to an overall
increase of 1.5 for combination, team, and more than 10 contact
hours (Table 2).56.4
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Fig. 6. Maximum DSM4. Discussion and conclusions
4.1. Discussion
Since the authorization of Medicare coverage for outpatient
diabetes self-management training in 1997, many randomized
controlled trials have been conducted to evaluate the impact of
DSME on clinical outcomes in individuals with T2DM. These
studies are vary with respect to a number of parameters including
methods and provider(s) of DSME, duration and intensity of as well
as content included in the education, follow-up interval and
participant characteristics. While not lending itself to meta-
analysis, this systematic review conﬁrms that DSME is associated
with signiﬁcant improvements in glycemic control. Notably, 61.9%
of interventions achieved statistically signiﬁcant and clinically
relevant improvements in A1C for participants engaged in DSME
compared with those who received no DSME. In addition, the
overall mean reduction in A1C for all participants randomized to
DSME was 0.74 compared with 0.17 for all participants randomized
to a CG. It is worth noting this absolute improvement in A1C of
0.57 is clinically meaningful and in the range of improvement seen
with the additional of several medications that may be added to a
primary glycemic control treatment regime. To explore the real
potential of DSME to improve glycemic control, we did a
subanalysis including only those studies that reported a statisti-
cally signiﬁcant decrease in A1C level with DSME as a surrogate
indicator for quality. Here the reductions in A1C ranged from
0.1 to 2.50 for DSME compared with a range of change for CG70.3
29.7
>10 hours
signiﬁcant
non-si gniﬁcant
E contact time.
Table 2
Change in A1C for intervention and control groups by DSME method, provider, and contact hours: all studies and studies with signiﬁcant decrease in A1C between
intervention group and control group.
Interventions
(n)
Mean (SD) Median Range Absolute difference in
A1C with the addition
of DSME
All Studies
IG CG IG CG IG CG
Total 118 0.74
(0.63)
0.17
(0.5)
0.60 0.12 2.5 to
0.6
1.7 to
1.5
0.57
Mode
 Combination 22 1.10
(0.6)
0.22
(0.62)
0.88 0.20 2.5 to
0.1
1.6 to
1.5
0.88
 Group 33 0.62
(0.46)
0.10
(0.42)
0.50 0.10 2.3 to
1.0
1.7 to
1.0
0.52
 Individual 47 0.78
(0.63)
-0.28
(0.46)
0.60 0.27 2.3 to
0.1
1.3 to
0.9
0.50
 Remote 12 0.50
(0.67)
0.17
(0.46)
0.22 0.08 2.2 to
0.2
0.9 to
0.7
0.33
Provider
 Single 69 0.74
(0.63)
0.17
(0.49)
0.60 0.10 2.5 to
0.6
1.6 to
1.1
0.57
 Team 46 0.74
(0.64)
0.18
(0.54)
0.60 0.20 2.3 to
0.1
1.7 to
1.5
0.56
Contact hours
 10 55 0.71
(0.55)
0.25
(0.47)
0.60 0.20 2.5 to
0.1
1.6 to
0.9
0.46
 >10 36 0.84
(0.65)
0.15
(0.55)
0.80 0.12 2.3 to
0.1
1.7 to
1.5
0.69
Studies with signiﬁcant decrease in A1C
Interventions
(n)
Mean (SD) Median Range Absolute difference in
A1C with the addition
of DSME
IG CG IG CG IG CG
Total 69 0.80
(0.58)
0.21
(0.47)
0.69 0.16 2.5 to
0.01
1.7 to
1.5
0.59
Mode
 Combination 18 1.22
(0.65)
0.14
(0.63)
1.1 0.1 2.5 to
0.4
1.6 to
1.5
1.08
 Group 22 0.71
(0.46)
0.13
(0.40)
0.6 0.02 2.3 to
0.23
1.7 to
0.3
0.58
 Individual 24 1.14
(0.6)
0.37
(0.42)
1.0 0.3 2.3 to
0.2
1.3 to
0.3
0.77
 Remote 5 0.86
(0.85)
0.03
(0.85)
0.8 0.1 2.2 to
0.01
0.9 to
0.7
0.83
Provider
 Single 38 1.03
(0.62)
0.18
(0.45)
0.8 0.1 2.5 to
0.01
1.6 to
0.7
0.85
 Team 30 1.00
(0.63)
0.25
(0.56)
0.9 0.2 2.3 to
0.2
1.7 to
1.5
0.75
Contact hours
 10 30 0.96
(0.56)
0.26
(0.47)
0.8 0.20 2.5 to
0.2
1.6 to
0.7
0.70
 >10 25 1.01
(0.65)
0.16
(0.56)
0.9 0.10 2.2 to
0.2
1.7 to
1.5
0.85
C.A. Chrvala et al. / Patient Education and Counseling 99 (2016) 926–943 939participants ranging from 1.5 to 1.7. The United Kingdom
Prospective Diabetes Study (UKPDS) revealed that a 0.9% decrease
in A1C was associated with a 25% reduction in microvascular
complications, a 10% decrease in diabetes-related mortality, and a
6% reduction in all-cause mortality [7].
We found that the magnitude of reductions in A1C in
participants exposed to DSME exceeded that of usual care by
more than 0.5% for all modes of delivery other than primarily
remote. However, our ﬁndings on remote interventions must be
interpreted with caution due to the small number of studies that
offered remote DSME (n = 12). With the advancement of technolo-
gy in the realm of web and remote applications they shouldcontinue to be explored and the potential remains to be
determined.
Importantly the most favorable effect on A1C is associated with
combination DSME with 0.88% reduction in A1C compared with
the control group. There was no difference in the mean
improvement in A1C between single and team DSME providers.
There was evidence to suggest that contact hours exceeding
10 were more often associated with DSME interventions resulting
in additional, statistically signiﬁcant, decreases in A1C. Although
the difference between A1C declines in the 10 hours and >10
hours was small, a much greater proportion (70.3%) of studies
providing 10 DSME hours demonstrated a statistically signiﬁcant
940 C.A. Chrvala et al. / Patient Education and Counseling 99 (2016) 926–943change in A1C compared with usual care. Further analysis by
method, provider, baseline A1C, duration of diabetes, and other
demographic and clinical characteristics may shed additional light
on this topic and provide useful policy information regarding
reimbursement for DSME. Currently, the Centers for Medicare and
Medicaid Services authorizes reimbursement for 1 hour of
individual DSMT and 9 hours offered as group education over 12
months, with 2 hours of follow-up education in either group or
individual settings reimbursed during each subsequent year.
Although additional research is needed to better establish
parameters for the optimal number of hours for different modes
and provider types of DSME, the data in this systematic review are
a ﬁrst step in providing some guidance.
Of note, our review demonstrates that DSME beneﬁted all
participants regardless of baseline A1C level. However, almost
two-thirds (65.6%) of studies that enrolled participants with
baseline A1C levels ranging from >8.3 to 9.0 reported a signiﬁcant
difference between the IG and CG and 78.1% of studies that enrolled
participants with baselines A1C levels >9.0 reported signiﬁcant
improvements in glycemic control in the IG compared with the CG.
Although the recommendation of the American Diabetes Associa-
tion [1] and others [155] is to engage individuals with diabetes
when they are ﬁrst diagnosed, it is our opinion that the results of
this review suggest that this may not be the case. Instead, we
suggest that the best time to engage individuals in DSME is when
they are ready to engage, i.e., when they are receptive or motivated
to engage in diabetes self-management strategies. Overall, our
ﬁndings suggest that current DSME interventions can be improved
through careful choice of method and possibly, provider and
contact time, although these ﬁndings will need to be conﬁrmed in
randomized controlled trials and observational studies.
Factors that may contribute to differences in observed out-
comes include the components and focus of the DSME interven-
tion, which was another area of intervention heterogeneity among
studies. For example, studies varied in their comprehensiveness in
terms of coverage of the seven AADE7TM Self-Care Behaviors. In
addition, subject demographics and clinical characteristics and the
structure of the healthcare system in which the DSME was offered
varied substantially between studies, including subject race/
ethnicity, duration of diabetes, different countries, and different
health care delivery systems.
The methodological limitations of the studies that were a part
of this systematic review included lack of blinding of assessor,
healthcare providers, and participants; potential for contamina-
tion between the IG and CG, unintended co-interventions, and the
failure to describe strategies to properly conceal study group
allocation. Most studies compared more intensive DSME with basic
care and education due to ethical concerns about withholding
education from the CG. This could have diminished the observed
effects of DSME. There were also inconsistencies in the manner in
which glycemic control was measured and reported. In addition,
studies used diverse statistical methods to analyze their ﬁndings,
with some relying on multivariate analyses that controlled for
possible confounders while others used Student’s t-test for
independent samples to compare mean A1C between study
groups or Pearson’s chi-square analysis to compare the percentage
of participants who met a discrete endpoint such as a prespeciﬁed
value for A1C reduction. A number of studies failed to provide a
detailed description of the DSME intervention and characteristics
of the study population and most studies relied on volunteer
participants, which limits generalizability of their results.
There are several limitations to this systematic review. First, we
restricted our selection of publications to English-language only
articles, though this is not considered to introduce systematic bias.
[147] We also limited studies to those that assessed changes in A1C
levels, although DSME is a behavioral intervention which focuseson self-management endpoints. This review included only
randomized controlled trials and the generalizability of these
ﬁndings to real-world settings may be limited the studies though
studies settings included several community based interventions.
Threats to internal validity were substantial with only 3 studies
fulﬁlling the 4 quality assessment criteria that indicated no known
selection, performance, attrition, or detection bias. By virtue of the
deﬁnition of DSME, it is not feasible to blind providers to random
assignment and few studies successfully blinded participants to
randomization. However these limitations are representative of
the ﬁeld having been present in systematic reviews conducted in
past decades [5,6,25,147] and the conclusions noted by Norris and
co-workers [5,6] remain relevant 14 years later.
4.2. Conclusion
The clinical implication of the favorable impact of DSME on
reductions in glycemic control is critically important because
glycemic control is among the strongest predictors of disease
progression and development of microvascular and macrovascular
complications in individuals with T2DM [148]. The data from the
UKPDS [7], suggests that this level of additional improvement in
A1C would be associated with better outcomes of signiﬁcance to
patients. This systematic review demonstrates that all methods of
DSME, delivered by either by a solo or team provider achieved
greater reductions in A1C compared with CG participants.
4.3. Practical implications
Quality diabetes care should include engagement in DSME
because it enhances the glycemic control seen with usual care.
Effective DSME must integrate practical and feasible educational
interventions that can be implemented in diverse settings. Having
people with diabetes participate in DSME should occur when they
are receptive to such engagement to maximize the potential of the
intervention to have an impact. Because DSME is currently a
heterogeneous intervention there is a need to assess and evaluate
its ability to generate clinically signiﬁcant changes in long-term
physiological outcomes, behavioral endpoints, and patient-
reported outcomes. In order to be relevant in today’s healthcare
marketplace, DSME must be relatively low-cost and cost-effective
[5,145], as well as a satisfying experience for recipients [5]. Our
results suggest that DSME has the potential to achieve clinically
meaningful reductions in A1C, with resultant complication risk
reduction. There is an imperative for methodologically rigorous
research conducted with diverse subject populations in various
real-world clinical and community settings to identify the
methods, providers, duration, and contact time that will yield
the most robust effects. Primary care physicians should refer their
patients to receive diabetes self-management education using the
diabetes education algorithm which deﬁnes 4 critical time points
for delivery and key information on the self-management skills
that are necessary at each of these critical periods [156]. Sample
referral forms with information needed for reimbursement are
available at: https://www.diabeteseducator.org/docs/default-
source/legacy-docs/_resources/pdf/general/Diabetes_Services_Or-
der_Form_v4.pdf.
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